Skip to main content
Clinical Trials/NL-OMON49521
NL-OMON49521
Withdrawn
Phase 2

DEBuT-LRP study: Non-invasive and Intravascular Identification and Drug-Eluting Balloon Treatment of Vulnerable Lipid-Rich Plaques - DEBuT-LRP

Academisch Medisch Centrum0 sites40 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
myocardial infarction
Sponsor
Academisch Medisch Centrum
Enrollment
40
Status
Withdrawn
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patient has an acute coronary syndrome without ST\-segment elevation on the
  • ECG (NSTE\-ACS), including non\-ST\-elevation myocardial infarction and unstable
  • angina pectoris.
  • 2\. An invasive revascularization strategy for NSTE\-ACS with PCI is chosen.
  • 3\. The coronary arteries are open and patent on CTCA, thus feasible to scan all
  • major coronary arteries with IVUS/NIRS.

Exclusion Criteria

  • Angiographic exclusion criteria:
  • 1\. Patient has additional lesions that cannot be treated during the index PCI
  • and need staged PCI;
  • 2\. A chronic total occlusion is present;
  • 3\. Previous coronary artery bypass\-grafting;
  • 4\. Patient has a major procedural complication of the index PCI (coronary
  • perforation, coronary dissection);
  • Clinical exclusion criteria:
  • 5\. Irregular heart rhythm, affecting the CT quality (i.e. atrial fibrillation
  • or frequent premature ventricular contractions);

Outcomes

Primary Outcomes

Not specified

Similar Trials